Pfizer/BioNTech: BNT162b1

Vaccine Type: RNA

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 2: 2 Trials

Phase 3: 1 Trial

  • NCT04368728
    Argentina, Brazil, Germany, South Africa, Turkey, United States of America

Approvals

This vaccine is not yet approved.

Registered Trials